Recent Finacing
Recent Raise
Conformation-X is an immune-oncology R&D company using a structure-informed discovery platform to develop selective immune checkpoint inhibitors (preclinical HHLA2 and IL18BP programs), affiliated with Pledge Therapeutics in Greater Boston.
Focus Areas
Total Raised
Funding round